US Drug Recall Register
Class III · Low risk Terminated Initiated Apr 9, 2013 (13 years ago)

Lisinopril Tablets

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Labeling: Label Error on Declared Strength: Incorrect strength on side display panel of label

What was recalled

Lisinopril Tablets, USP, 30 mg, Rx only, 100 tablets, NDC 65862-041-01 Manufactured for: Aurobindo Pharma USA Inc. 2400 Route 130 North, Dayton, NJ 08810 Manufactured by: Aurobindo Pharma Limited Hyderabad- 500 072 India

Recalling firm
Aurobindo Pharma USA Inc
NDC code
65862-041-01
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-498-2013

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Lisinopril recalls

See all
Class II · Moderate risk Ongoing

Lisinopril and Hydrochlorothiazide Tablets USP 20mg/12.5mg

Reason Product Mix Up: This product is being recalled because of a complaint received that a sealed bottle of lisinopril and hydrochlorothiazide tablets 20mg/12.5 mg had a foreign tablet identified as atazanavir and ritonavir tablet 300mg/100mg.

Lupin Pharmaceuticals Inc. NDC 68180-519-01 D-0532-2025
Class II · Moderate risk Terminated

Lisinopril Tablets

Reason Presence of Foreign Object: A pharmacist discovered a metal fragment embedded in a lisinopril 10 mg tablet.

Evaric Pharmaceuticals Inc. NDC 68645-610-90 D-0061-2025
Class III · Low risk Terminated

Lisinopril Tablets USP 20 mg

Reason Presence of Foreign Tablets: Potential of stray tablet(s) of Amlodipine Besylate 10 mg Tablet within the recalled lots

NCS Healthcare of Kentucky Inc NDC 0615-7718-05 D-0114-2024
Class II · Moderate risk Terminated

Lisinopril 10 mg tablets

Reason Presence of Foreign Substance: Foreign material (metal piece) embedded in one tablet.

RemedyRepack Inc. NDC 68180-0980-03 D-1538-2022
Class II · Moderate risk Terminated

Lisinopril Tablets USP

Reason Presence of Foreign Substance: Foreign material (metal piece) embedded in one tablet.

Lupin Pharmaceuticals Inc. NDC 68180-980-03 D-1536-2022